It has been observed that patients with MDD treated pharmacologically had significantly lower IGF-1 levels in comparison with the untreated group (B = −1.71 95% CI = −2.32 to −1.09, p < 0.001) [44]. Here, IGF1 is linked to major depressive disorder.